Artur Racewicz
- Rheumatology top 1%
- Immunology top 5%
- Genetics top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Hematology top 5%
- Co-authors
- Ronald van VollenhovenSunil AgarwalL SzczepańskiRoy FleischmannE. HesseyJoy SchechtmanPaul EmeryNicole F. Li
- Topics
- Biosimilars and Bioanalytical Methods (8 papers)Rheumatoid Arthritis Research and Therapies (7 papers)Pharmaceutical studies and practices (6 papers)
- Cited by
- RheumatologyGeneticsImmunology
- Partner nations
- PolandUnited StatesSouth Korea
In The Last Decade
Artur Racewicz
13 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Rheumatology 933
- Immunology 660
- Genetics 344
- Radiology, Nuclear Medicine and Imaging 325
- Hematology 304
Countries citing papers authored by Artur Racewicz
This map shows the geographic impact of Artur Racewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artur Racewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artur Racewicz more than expected).
Fields of papers citing papers by Artur Racewicz
This network shows the impact of papers produced by Artur Racewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artur Racewicz. The network helps show where Artur Racewicz may publish in the future.
Co-authorship network of co-authors of Artur Racewicz
This figure shows the co-authorship network connecting the top 25 collaborators of Artur Racewicz. A scholar is included among the top collaborators of Artur Racewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artur Racewicz. Artur Racewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 101 | |
| 4 | 110 | |
| 5 | 137 | |
| 6 | 7 | |
| 7 | Sustained Efficacy and Comparable Safety and Immunogenicity after Transition to SB5 (an Adalimumab Biosimilar) Vs. Continuation of SB5 or Reference Adalimumab (Humira®) in Patients with Rheumatoid Arthritis: Results of Phase III Study | 3 |
| 8 | 21 | |
| 9 | 21 | |
| 10 | 253 | |
| 11 | 17 | |
| 12 | 66 | |
| 13 | 4 | |
| 14 | The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trialbreakdown → | 783 |
About Artur Racewicz
Artur Racewicz is a scholar working on Rheumatology, Immunology and Orthopedics and Sports Medicine, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Pharmaceutical studies and practices (6 papers). The work is most often cited by research in Rheumatology (933 citations), Genetics (344 citations) and Immunology (660 citations). Artur Racewicz has collaborated with scholars based in Poland, United States and South Korea. Frequent co-authors include Ronald van Vollenhoven, Sunil Agarwal, L Szczepański, Roy Fleischmann, E. Hessey, Joy Schechtman, Paul Emery, Nicole F. Li, Anna Filipowicz‐Sosnowska and Arthur Kavanaugh. Their work appears in journals such as Annals of the Rheumatic Diseases, Bone and Osteoporosis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.